DrugBank ID
stringlengths 7
7
| Accession Numbers
stringlengths 7
102
⌀ | Common name
stringlengths 3
226
| CAS
stringlengths 7
12
⌀ | UNII
stringlengths 10
10
⌀ | Synonyms
stringlengths 2
1.48k
⌀ | Standard InChI Key
stringlengths 27
27
⌀ |
|---|---|---|---|---|---|---|
DB18293
| null |
CM-101
| null | null |
Monoclonal antibody targeting CCL24 | Monoclonal antibody targeting eotaxin-2
| null |
DB18294
| null |
AVR-48
|
3459-18-5
|
GVY9AA7Y5C
|
.beta.-d-glucopyranoside, 4-nitrophenyl 2-(acetylamino)-2-deoxy- | 4-nitrophenyl 2-acetamido-2-deoxy-beta-d-glucopyranoside | 4-nitrophenyl-n-acetyl-beta-d-glucosaminide | N-((2s,3r,4r,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-2-(4-nitrophenoxy)tetrahydro-2h-pyran-3-yl) acetamide | N-((2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-(4-nitrophenoxy)tetrahydro-2H-pyran-3-yl)acetamide
|
OMRLTNCLYHKQCK-DHGKCCLASA-N
|
DB18295
| null |
BN-201
|
1361200-34-1
|
KCN37L7EIH
|
Glycinamide, n-(2-(2-fluorophenyl)ethyl)glycyl-n-(2-methylpropyl)glycyl-n2-(3-(2-oxo-1-pyrrolidinyl)propyl)- | N-(2-amino-2-oxoethyl)-2-(2-((4-fluorophenethyl)amino)-N-isobutylacetamido)-N-(3-(2-oxopyrrolidin-1-yl)propyl)acetamide N-({Carbamoylmethyl-[3-(2-oxo-pyrrolidin-1-yl)propyl}-carbamoyl}-methyl)-2-[2-(2-fluorophenyl)-ethylamino]-N-isobutyl-acetamide
|
ODCKWAPNRBCXHV-UHFFFAOYSA-N
|
DB18296
| null |
AB-22
|
1463913-43-0
|
R228S06SOH
|
Hydrazinecarboxamide, n-(2-chloro-6-propoxy-4-pyridinyl)-2-(1,3-dimethyl-4-(1-methylethyl)-1h-pyrazolo(3,4-b)pyridin-6-yl)-2-(2-hydroxyethyl)- | N-(2-chloro-6-propoxypyridin-4-yl)-2-(2-hydroxyethyl)-2-(4-isopropyl-1,3-dimethyl-1h-pyrazolo(3,4-b)pyridin-6-yl)hydrazinecarboxamide | N-(2-chloro-6-propoxypyridin-4-yl)-2-(2-hydroxyethyl)-2-(4-isopropyl-1,3-dimethyl-1H-pyrazolo[3,4-b]pyridin-6-yl)hydrazinecarboxamide
|
GOQBSVFOBGVWTA-UHFFFAOYSA-N
|
DB18297
| null |
KF-1601
|
2699634-21-2
|
A3F7DA3SGX
|
Benzamide, N-[3-(1-cyano-1-methylethyl)-5-(4-methyl-1H-imidazol-1-yl)phenyl]-2-fluoro-4-methyl-5-[2-[8-[(1-methyl-1H-pyrazol-4-yl)amino]imidazo[1,2-a]pyridin-3-yl]ethynyl]- | N-(3-(2-cyanopropan-2-yl)-5-(4-methyl-1H-imidazol-1-yl)phenyl)-2-fluoro-4-methyl-5-((8-((1-methyl-1H-pyrazol-4-yl)amino)imidazo[1,2-a]pyridin-3-yl)ethynyl)benzamide
|
ZYJGSUKMQPXJRU-UHFFFAOYSA-N
|
DB18298
| null |
PTI-110
|
633700-15-9
|
YI3H6V056C
|
3,4-dihydroxybenzoic acid 3,4-dihydroxyanilide | Benzamide, n-(3,4-dihydroxyphenyl)-3,4-dihydroxy- | N-(3,4-dihydroxyphenyl)-3,4-dihydroxybenzamide | Systebryl
|
XIKSEDLKDYKPTO-UHFFFAOYSA-N
|
DB18299
| null |
N-(4-(1-cyclopropyl-4-fluoro-2-methyl-1H-benzo(d)imidazol-6-yl)-5-fluoropyrimidin-2-yl)-6-(2-(dimethylamino)ethyl)-5,6,7,8-tetrahydro-l,6-naphthyridin-2-amine
|
2102887-41-0
|
484EDA7KEM
| null |
UZUCFTPPULEGQO-UHFFFAOYSA-N
|
DB18300
| null |
Lirafugratinib
|
2549174-42-5
|
7HY6IMH87S
|
2-Propenamide, N-[4-[4-amino-5-[3-fluoro-4-[(4-methyl-2-pyrimidinyl)oxy]phenyl]-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]-2-methyl- | N-(4-(4-amino-5-(3-fluoro-4-((4-methylpyrimidin-2-yl)oxy)phenyl)-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl)methacrylamide | N-[4-(4-amino-5-{3-fluoro-4-[(4-methylpyrimidin-2- yl)oxy]phenyl}-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-6- yl)phenyl]-2-methylprop-2-enamide
|
XOQVZSSDIQQUGO-UHFFFAOYSA-N
|
DB18301
| null |
Dazcapistat
|
2221010-42-8
|
AX895U92WU
|
5-oxazolecarboxamide, n-(3-amino-2,3-dioxo-1-(phenylmethyl)propyl)-4-(2-fluorophenyl)-2-methyl- | N-(3-amino-2,3-dioxo-1-(phenylmethyl)propyl)-4-(2-fluorophenyl)-2-methyl-5-oxazolecarboxamide | N-(4-amino-3,4-dioxo-1-phenylbutan-2-yl)-4-(2-fluorophenyl)-2-methyloxazole-5-carboxamide
|
XYQHCMDVGIJOTA-UHFFFAOYSA-N
|
DB18302
| null |
NTP-42
|
2055599-51-2
|
2057H3EG0S
|
Benzenesulfonamide, 5-cyano-2-((4'-(difluoromethoxy)(1,1'-biphenyl)-3-yl)oxy)-n-(((1,1-dimethylethyl)amino)carbonyl)- | N-(tert-butylcarbamoyl)-5-cyano-2-((4'-(difluoromethoxy)-(1,1'-biphenyl)-3-yl)oxy)benzenesulfonamide
|
RIIKDGPBTPECSW-UHFFFAOYSA-N
|
DB18303
| null |
Deucrictibant
|
2340111-58-0
|
69GCA2KX22
|
Acetamide, N-[(1S)-1-[3-chloro-5-fluoro-2-[[[2-methyl-4-(1-methyl-1H-1,2,4-triazol-5- yl)-8-quinolinyl]oxy]methyl]phenyl]ethyl-1-d]-2-(difluoromethoxy)- | N-[(1S)-1-[3-chloro-5-fluoro-2-({[2-methyl-4-(1-methyl-1H-1,2,4-triazol-5-yl)quinolin-8-yl]oxy}methyl)phenyl](1-2H)ethyl]-2-(difluoromethoxy)acetamide | N-{(1S)-1-[3-chloro-5-fluoro-2-({[2-methyl-4-(1-methyl-1H-1,2,4-triazol-5-yl)quinolin-8- yl]oxy}methyl)phenyl](1-2H)ethyl}-2-(difluoromethoxy)acetamide
|
ZTCLCSCHTACERP-WTDRUJNCSA-N
|
DB18304
| null |
Emlenoflast
|
1995067-59-8
|
SC4RYG0M76
|
1h-pyrazole-3-sulfonamide, n-(((1,2,3,5,6,7-hexahydro-s-indacen-4-yl)amino)carbonyl)-1-(1-methylethyl)- | Inzomelid | N-[[(1,2,3,5,6,7-HEXAHYDRO-S-INDACEN-4-YL) AMINO]CARBONYL]-1-(1-METHYLETHYL)-1H-PYRAZOLE-3-SULFONAMIDE
|
MTOUOUSKXWSTAX-UHFFFAOYSA-N
|
DB18305
| null |
Sebetralstat
|
1933514-13-6
|
O5ZD2TU2B7
|
1H-Pyrazole-4-carboxamide, N-[(3-fluoro-4-methoxy-2-pyridinyl)methyl]-3-methoxymethyl)-1-[[4-[(2-oxo-1(2H)-pyridinyl)methyl]phenyl]methyl]- | N-[(3-fluoro-4-methoxypyridin-2-yl) methyl]-3-(methoxymethyl)-1-({4-[(2-oxo-1,2-dihydropyridin-1-yl) methyl]phenyl}methyl)-1H-pyrazole-4-carboxamide | N-[(3-fluoro-4-methoxypyridin-2-yl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1(2H)-yl)methyl]phenyl}methyl)-1H-pyrazol-4-carboxamide
|
KGMPDQIYDKKXRD-UHFFFAOYSA-N
|
DB18306
| null |
TSN-084
|
2412309-60-3
|
9FJ3MBL7XW
|
3-PYRIDINECARBOXAMIDE, N-(3-FLUORO-4-((1-METHYL-6-(1H-PYRAZOL-4-YL)-1H-INDAZOL-5-YL)OXY)PHENYL)-1-(4-FLUOROPHENYL)-1,2-DIHYDRO-6-(1-METHYLETHOXY)-2-OXO- | N-[3-fluoro-4-[[1-methyl-6-(1H-pyrazol-4-yl)-1H-indazol-5-yl]oxy]phenyl]-1-(4-fluorophenyl)-1,2-dihydro-6-(1-methylethoxy)-2-oxo-3-pyridinecarboxamide
|
XSDZOIYDMHIIAQ-UHFFFAOYSA-N
|
DB18307
| null |
VLX-1005
|
1532593-30-8
|
JKU4XCC48Y
|
Benzenesulfonamide, n-2-benzothiazolyl-4-(((2-hydroxy-3-methoxyphenyl)methyl)amino)- | N-2-benzothiazolyl-4-(((2-hydroxy-3-methoxyphenyl)methyl)amino)benzenesulfonamide | N-Benzothiazol-2-yl-4-(2-hydroxy-3-methoxy-benzylamino)-bezenesulfonamide
|
OWHBVKBNNRYMIN-UHFFFAOYSA-N
|
DB18308
| null |
N,N-dimethyl-N-(2-(((2R,3R,4S,5R,6R)-3,4,5-tris(acetyloxy)-6-((acetyloxy)methyl)oxan-2-yl)oxy)ethyl)cyclopropylammonium
|
2440155-89-3
|
J6QN4FZ2UG
| null |
FOZFSJHFTYNIRJ-YMQHIKHWSA-N
|
DB18309
| null |
SEA-BCMA
|
2115084-53-0
|
3C28VJ95EV
|
Anti-bcma antibody sea-bcma | Nonfucosylated humanized immunoglobulin G1 (IgG1) monoclonal antibody targeting B-cell maturation antigen (SEA-BCMA)
| null |
DB18310
| null |
Recilisib
|
334969-03-8
|
F5V4K11SYV
|
4-((1e)-2-(((4-chlorophenyl)methyl)sulfonyl)ethenyl)benzoic acid | Benzoic acid, 4-((1e)-2-(((4-chlorophenyl)methyl)sulfonyl)ethenyl)-
|
KBEKQQJUNVQLDZ-MDZDMXLPSA-N
|
DB18311
| null |
Taniraleucel
| null |
XO25H8E4QP
|
Allogeneic natural killer (NK) cells derived from CD34+ human placental stem/progenitor cells. The cells are expanded and differentiated in the presence of cytokines including thrombopoietin, SCF, Flt3 ligand, IL-7, IL-15 and IL-2 to generate the NK cell | ALLOGENEIC UMBILICAL CORD BLOOD-DERIVED, CULTURE-EXPANDED NATURAL KILLER CELLS
| null |
DB18312
| null |
Telitacicept
|
2136630-26-5
|
1FHM3D7Z49
|
(L120>A,L121>E,G123>A,A216>S,P217>S)-TACI (TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR, TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY PROTEIN TNFRSF13B) HUMAN EXTRACELLULAR DOMAIN FRAGMENT (13-118)-PEPTIDE (1-106) FUSION PROTEIN WITH HUMAN IMMUNOGLOBULIN G1 | 13-118-tumor necrosis factor receptor superfamily protein tnfrsf13b (human extracellular domain fragment) fusion protein with immunoglobulin g1, (human rc18 fc fragment), dimer
| null |
DB18313
| null |
Cinnamic acid
|
140-10-3
|
U14A832J8D
|
2-propenoic acid, 3-phenyl- | 2-propenoic acid, 3-phenyl-, (2e)- | 2-propenoic acid, 3-phenyl-, (e)- | 3-phenyl-2-propenoic acid | 3-phenylacrylic acid | 3-phenylpropenoic acid | Cinnamic acid (constituent of cinnamomum verum bark) | Cinnamic acid, (e)- | Cinnamic acid, trans- | Cinnamic acidum | E-cinnamic acid | Trans-cinnamic acid | Trans-cinnamic acid (constituent of cinnamomum cassia bark)
|
WBYWAXJHAXSJNI-VOTSOKGWSA-N
|
DB18314
| null |
Valemetostat
|
1809336-39-7
|
60RD0234VE
|
Ezh1/2 inhibitor ds-3201
|
SSDRNUPMYCFXGM-UYPAYLBCSA-N
|
DB18315
| null |
Zagociguat
|
2201048-82-8
|
H7KEN3O8AI
|
CY6463 | Zagociguat
|
GTKNNCQKFKGSHR-UHFFFAOYSA-N
|
DB18316
| null |
CTB001
| null | null | null | null |
DB18317
| null |
UX701
| null | null | null | null |
DB18318
| null |
M002
| null | null | null | null |
DB18319
| null |
4D-110
| null | null | null | null |
DB18320
| null |
AXV101
| null | null | null | null |
DB18321
| null |
JAG101
| null | null | null | null |
DB18322
| null |
NCATS-BL0746
| null | null | null | null |
DB18323
| null |
4D-310
| null | null | null | null |
DB18324
| null |
BMN-331
| null | null | null | null |
DB18325
| null |
OptPA
| null | null |
Pptimized human tissue-type plasminogen activator | W253R/R275S-tPA
| null |
DB18326
| null |
OCU410ST
| null | null | null | null |
DB18327
| null |
ATSN-101
| null | null | null | null |
DB18328
| null |
TSHA-105
| null | null | null | null |
DB18329
| null |
ATA-100
| null | null | null | null |
DB18330
| null |
Yinfenidone
| null | null |
Hec585 | Yinfenidone
| null |
DB18331
| null |
LB54640
| null | null |
Oral melanocortin 4 receptor agonist | Small molecule melanocortin 4 receptor agonist
| null |
DB18332
| null |
Phelimin
| null | null | null | null |
DB18333
| null |
BT200
| null | null |
PEGylated aptamer targeting Von Willebrand Factor A1 domain | Rondoraptivon pegol
| null |
DB18334
| null |
MPB-1523
| null | null |
PEGylated iron oxide nanoparticles
| null |
DB18335
| null |
NGN-101
| null | null | null | null |
DB18336
| null |
TLY-012
| null |
S4LKC378SN
| null | null |
DB18337
| null |
GS-100
| null | null | null | null |
DB18338
| null |
HMI-204
| null | null | null | null |
DB18339
| null |
RP-A601
| null | null | null | null |
DB18340
| null |
FBX-101
| null | null | null | null |
DB18341
| null |
ADVM-062
| null | null | null | null |
DB18342
| null |
PRGN-2012
| null | null | null | null |
DB18343
| null |
AAV-RPE65
| null | null | null | null |
DB18344
| null |
AAV-CNGB3
| null | null | null | null |
DB18345
| null |
CN-105
|
1632243-07-2
|
W525NLS74J
|
Ac-VSRRR- NH2
|
ZPSIKZCGZCSUNF-HVTWWXFQSA-N
|
DB18346
| null |
AMG-553
| null | null | null | null |
DB18347
| null |
Hu-PHEC Liver
| null | null | null | null |
DB18348
| null |
Peptide YY (1-36)
|
118997-30-1
|
T2670C12I5
|
Peptide YY | Peptide YY (human) | Peptide YY human | Peptide YY human (1-36) | Tyr-pro-ile-lys-pro-glu-ala-pro-gly-glu-asp-ala-ser-pro-glu-glu-leu-asn-arg-tyr-tyr-ala-ser-leu-arg-his-tyr-leu-asn-leu-val-thr-arg-gln-arg-tyr-nh2
| null |
DB18349
| null |
Allogeneic ABCB5-positive limbal stem cells
| null | null | null | null |
DB18350
| null |
WU-NK-101
| null | null | null | null |
DB18351
| null |
Nendratareotide uzatansine
|
1853254-97-3
|
L8993M383E
|
Nendratareotide uzatansine | Peptide-drug conjugate combining [(Tyr3,Cys8) octreotate amide] and N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl) maytansine
| null |
DB18352
| null |
TCB-008
| null | null | null | null |
DB18353
| null |
Ananain
|
119129-70-3
|
K0H66D72UT
|
Ananain (ec:3.4.22.31) | Bromelain, ananain-
| null |
DB18354
| null |
Comosain
| null |
55MVW171WS
| null | null |
DB18355
| null |
Riliprubart
|
2756228-76-7
|
I31869XDP8
| null | null |
DB18356
| null |
Inaticabtagene Autoleucel
| null | null | null | null |
DB18357
| null |
T-Guard
| null | null | null | null |
DB18358
| null |
EO-3021
| null | null | null | null |
DB18359
| null |
LT2003
| null | null | null | null |
DB18360
| null |
MEDI-547
| null |
D21E6RU881
| null | null |
DB18361
| null |
NNC0114-0006
| null |
L1SQ55DADE
| null | null |
DB18362
| null |
EB003
| null | null |
Phage-derived, non-replicative delivery vector carrying a DNA payload encoding an RNA-guided nuclease that targets stx genes of Shiga toxin-producing Escherichia coli (STEC)
| null |
DB18363
| null |
E1v1.11
| null | null |
Phosphorodiamidate morpholino oligomer (5'- CTATATATAGTTATTCAACA -3')
| null |
DB18364
| null |
BRM-421
| null | null |
Pigment Epithelium Derived Factor derived short peptide (Ac-Ser-Leu-Gly-Ala-Glu-Gln-Arg-Thr-Glu-Ser-Ile-Ile-His-Arg-Ala- Leu-Tyr-Tyr-Asp-Leu-Ile-Ser-Ser-Pro-Asp-Ile-His-Gly-Thr-NH2)
| null |
DB18365
| null |
S-55746
|
1448584-12-0
|
W93257I68I
|
(S)-N-(4-hydroxyphenyl)-3-(6-(3-(morpholinomethyl)-1,2,3,4-tetrahydroisoquinoline-2-carbonyl)benzo(d)(1,3)dioxol-5-yl)-n-phenyl-5,6,7,8-tetrahydroindolizine-1-carboxamide
|
VYXJULKGMXJVGI-XIFFEERXSA-N
|
DB18366
| null |
NXC680
| null | null | null | null |
DB18367
| null |
Allogeneic umbilical cord mesenchymal stem cells
| null | null |
Allogeneic umbilical cord mesenchymal stem cells | Allogeneic umbilical cord-derived mesenchymal stem cells | Allogenic umbilical cord mesenchymal stem cells | Allogenic umbilical cord-derived mesenchymal stem cells
| null |
DB18368
| null |
Tiprelestat
|
820211-82-3
|
78I8295690
|
Elastase-specific inhibitor, skin-derived antileukoproteinase, peptidase inhibitor 3 | Human elafin | Recombinant elafin
| null |
DB18369
| null |
Lyophilized activated platelets
| null | null | null | null |
DB18370
| null |
SMART101
| null | null | null | null |
DB18371
| null |
Zafiride
| null | null |
CNGRC peptide-TNF alpha conjugate | NGR TNF | NGR-TNFα | Tumour-homing-peptide-tumour-necrosis-factor-alpha-fusion-protein | Tumour-vasculature-targeted-tumour-necrosis-factor-alpha
| null |
DB18372
| null |
E59
| null | null | null | null |
DB18373
| null |
Vanzacaftor
|
2374124-49-7
|
COM1POP492
|
Vanzacaftor | VX-121
|
VCSUIBJKYCVWNF-NRFANRHFSA-N
|
DB18374
| null |
Cevostamab
|
2249888-53-5
|
P86BHN01VE
|
Anti-fcrh5/cd3 bite antibody bfcr4350a | Bfcr4350a (anti-fcrh5/cd3 t-cell dependent bispecific antibody) | Cevostamab | Fcrh5/cd3 t cell dependent bispecific antibody bfcr4350a | Recombinant anti-fcrh5 x anti-cd3 bi-specific t-cell engager bfcr4350a
| null |
DB18375
| null |
PNT001
| null | null | null | null |
DB18376
| null |
TORL-2-307
| null | null | null | null |
DB18377
| null |
SGN-B6A
|
2764774-91-4
|
QX0ONY0O9T
|
Sigvotatug vedotin
| null |
DB18378
| null |
CALY-002
| null | null | null | null |
DB18379
| null |
ART5803
| null | null | null | null |
DB18380
| null |
XTMAB-16
| null | null | null | null |
DB18381
| null |
IVT-8086
| null | null | null | null |
DB18382
| null |
PYX-201
| null | null | null | null |
DB18383
| null |
MDX-1097
| null | null | null | null |
DB18384
| null |
INBRX-101
| null | null | null | null |
DB18385
| null |
VGA039
| null | null | null | null |
DB18386
| null |
AV-0113
| null |
H2CDQ1PWN7
| null | null |
DB18387
| null |
GB-13
| null | null | null | null |
DB18388
| null |
LIS-1
| null | null | null | null |
DB18389
| null |
CAN-106
| null | null |
Immunoglobulin G [27-histidine,57-histidine,253-tyrosine,255- threonine,257-glutamic acid], anti-(human complement C5) (human monoclonal CAN106 hybrid y2-chain CH1-hinge region/y4-chain CH2- CH3 region), disulfide with human monoclonal CAN106 Kappa-chain, dimer
| null |
DB18390
| null |
DPM-1001
|
1471172-29-8
|
4EA2U2RX2G
|
Cholan-24-oic acid, 7-hydroxy-3-[[4-[(2-pyridinylmethyl)amino]butyl]amino]-, methyl ester, (3β,5α,7α)- | Methyl (3β,5α,7α)-7-hydroxy-3-[[4-[(2-pyridinylmethyl)amino]butyl]amino]cholan-24-oate | methyl (R)-4-((3S,5R,7R,8R,9S,10S,13R,14S,17R)-7-hydroxy-10,13-dimethyl-3-((4-((pyridin-2-ylmethyl)amino)butyl)amino)hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoate
|
RVANDQULNPITCN-PTSOVGQSSA-N
|
DB18391
| null |
Fenvalerate
|
51630-58-1
|
Z6MXZ39302
|
(.alpha.rs)-.alpha.-cyano-3-phenoxybenzyl (2rs)-2-(4-chlorophenyl)-3-methylbutyrate | (rs)-.alpha.-cyano-3-phenoxybenzyl (rs)-2-(4-chloro-phenyl)-3-methylbutyrate | Belmark | Benzeneacetic acid, 4-chloro-.alpha.-(1-methylethyl)-, cyano(3-phenoxyphenyl)methyl ester | Cyano(3-phenoxyphenyl)methyl 4-chloro-.alpha.-(1-methylethyl)benzeneacetate | methyl (R)-4-((3S,5R,7R,8R,9S,10S,13R,14S,17R)-7-hydroxy-10,13-dimethyl-3-((4-((pyridin-3- ylmethyl)amino)butyl)amino)hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoate | Phenvalerate | Pydrin | Pyridin | Sumicidin | Tirade
|
NYPJDWWKZLNGGM-UHFFFAOYSA-N
|
DB18392
| null |
NV-354
|
866465-21-6
|
4GF65YYK2S
|
Butanoic acid, 4-[[2-(acetylamino)ethyl]thio]-4-oxo-, methyl ester | Methyl 4-{[2-(acetamino)ethyl]sulfanyl}-4-oxobutanoate
|
LCEITCPWQIJXGQ-UHFFFAOYSA-N
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.